Literature DB >> 31657225

Role of gut microbiota in liver disease.

Somaya A M Albhaisi1, Jasmohan S Bajaj2, Arun J Sanyal3.   

Abstract

The gut microbiome is the natural intestinal inhabitant that has been recognized recently as a major player in the maintenance of human health and the pathophysiology of many diseases. Those commensals produce metabolites that have various effects on host biological functions. Therefore, alterations in the normal composition or diversity of microbiome have been implicated in various diseases, including liver cirrhosis and nonalcoholic fatty liver disease. Moreover, accumulating evidence suggests that progression of dysbiosis can be associated with worsening of liver disease. Here, we review the possible roles for gut microbiota in the development, progression, and complication of liver disease.

Entities:  

Keywords:  alcoholic hepatitis; bacteria; cirrhosis; gut microbiota; hepatocellular cancer; intestinal microbiome; metagenomics; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis

Mesh:

Year:  2019        PMID: 31657225     DOI: 10.1152/ajpgi.00118.2019

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  29 in total

Review 1.  The Influence of the Microbiome on NAFLD and NASH.

Authors:  Somaya A M Albhaisi; Jasmohan S Bajaj
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-02-01

Review 2.  Hepatocellular Cancer and Gut Microbiome: Time to Untie Gordian's Knot.

Authors:  Cem Aygün; Nurdan Tözün
Journal:  J Gastrointest Cancer       Date:  2021-11-08

Review 3.  Gut Microbiome and Alcohol-associated Liver Disease.

Authors:  Cyriac A Philips; Bernd Schnabl; Jasmohan S Bajaj
Journal:  J Clin Exp Hepatol       Date:  2022-01-04

Review 4.  A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Hepatic Encephalopathy and Clostridioides difficile Infection in Patients With Cirrhosis.

Authors:  Kyaw Min Tun; Annie S Hong; Kavita Batra; Yassin Naga; Gordon Ohning
Journal:  Cureus       Date:  2022-05-31

5.  Host miRNA-21 promotes liver dysfunction by targeting small intestinal Lactobacillus in mice.

Authors:  André A Santos; Marta B Afonso; Ricardo S Ramiro; David Pires; Madalena Pimentel; Rui E Castro; Cecília M P Rodrigues
Journal:  Gut Microbes       Date:  2020-11-09

Review 6.  Fungi, host immune response, and tumorigenesis.

Authors:  Miar Elaskandrany; Rohin Patel; Mintoo Patel; George Miller; Deepak Saxena; Anjana Saxena
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-07-07       Impact factor: 4.871

Review 7.  Is it time for microbiome-based therapies in viral infections?

Authors:  Faizan Ahmed Sadiq
Journal:  Virus Res       Date:  2020-10-22       Impact factor: 6.286

Review 8.  Metabolic drivers of non-alcoholic fatty liver disease.

Authors:  Kendra K Bence; Morris J Birnbaum
Journal:  Mol Metab       Date:  2020-12-17       Impact factor: 7.422

Review 9.  A Review of Pharmacology, Toxicity and Pharmacokinetics of 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-Glucoside.

Authors:  Cheng Wang; Shu Dai; Lihong Gong; Ke Fu; Cheng Ma; Yanfang Liu; Honglin Zhou; Yunxia Li
Journal:  Front Pharmacol       Date:  2022-01-05       Impact factor: 5.810

Review 10.  Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis.

Authors:  Somaya Albhaisi; Arun J Sanyal
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-10       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.